1. Karvonen M, et al. Magnetocardiographic indices of left ventricular hypertrophy. J Hypertens. 2002;20(11):2285-92.
2. Heckbert SR, et al. Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: the Multiethnic Study of Atherosclerosis. J Am Coll Cardiol. 2006;22:2285-92.
3. Bluemke DA, et al. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol. 2008;52(25):2148-55.
4. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287(10);1308-20.
5. Maron BJ, et al. Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1986;8(3):545-57.
6. Maron MS, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003;348:295-303.
7. Gersh BJ, et al. ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidlines. Circulation. 2011;146(124):2761-96.
8. Maron BJ, et al. Sudden death in hypertrophic cardiomyopathy. A profile of 78 patients. Circulation. 1982;65:1388-94.
9. Sinitsyn VE, et al. Vozmozhnosti magnitno-rezonansnoy tomografii v diagnostike kardiomiopatiy. Klinicheskaya i eksperimentalnaya chirurgiya. 2014;1:54-63.
10. Elliott PM, et al. Sudden death in hypertrophic cardiomyopathy. Identification of high risk patients. J Am Coll Cardiol. 2000;36:2212-8.
11. Maki S, et al. Predictors of sudden cardiac death in hypertrophic cardiomyopathy. Am J Cardiol. 1998;82:774-8.
12. Cenacchi G, Papa V, et al. Review: Danon disease: Review of natural history and recent advances. Neuropathology and Applied Neurobiology. 2019.